Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, USA.
Department of Neurologic Surgery, Medical University of South Carolina, SC, USA.
J Stroke Cerebrovasc Dis. 2024 Jun;33(6):107679. doi: 10.1016/j.jstrokecerebrovasdis.2024.107679. Epub 2024 Mar 17.
Anterior choroidal artery (AchoA) aneurysms are relatively rare compared to other types of aneurysms. However, the occurrence of transient or permanent occlusion of the choroidal artery during endovascular or surgical treatment is an uncommon but potentially serious complication. In this study, we aim to investigate the safety and efficacy profile of endovascular treatment (EVT) for AchoA aneurysms.
The primary outcome of interest was angiographic and clinical outcomes. Secondary outcome variables transient and permanent ischemic complications, symptomatic choroidal artery occlusion and retreatment rates. A random-effects model was used to calculate prevalence rates and their corresponding 95 % confidence intervals (CI), and subgroup analyses were performed to assess the complication rates for Type 1(arterial type, directly arising from ICA) and Type 2(neck type, arising from AchoA branch)) AchoA aneurysms, ruptured vs non-ruptured and for flow diverter (FD) treatment versus coiling.
Our study included 10 studies with 416 patients with 430 AchoA aneurysms. The overall good clinical outcome rate (mRS score 0-2) is 94.5 % with a retreatment rate of 2.0 %. A subgroup analysis showed no statistical difference between coiling(75.3 %) and flow diverter(80.9 %) treatment in terms of complete occlusion(p-value:0.62). Overall permanent complication rate is 1.4 % (p-value:0.54) and transient ischemic complications rate is 4.2 %(p-value:0.61). Symptomatic choroidal artery occlusion rate is 0.8 %(p-value:0.51)Type 2 AchoA aneurysms had a significantly higher complication rate of 9.8 % (p-value<0.05) compared to Type 1 aneurysms. Unruptured aneurysms have significantly better clinical outcomes than ruptured aneurysms(OR: 0.11; [0.02;0.5], p-value:<0.05) CONCLUSION: Endovascular treatment of AchoA aneurysms demonstrated positive clinical results, with low rates of retreatment and complications. Coiling and flow diverters proved similar outcomes in achieving aneurysm occlusion. Ruptured aneurysms have lower good clinical outcomes comparing to unruptured aneurysms. Type 2 AchoA aneurysms had a higher risk of complications compared to Type 1.
与其他类型的动脉瘤相比,前脉络膜动脉(AchoA)动脉瘤相对较少见。然而,在血管内或手术治疗过程中脉络膜动脉出现短暂或永久性闭塞是一种罕见但潜在严重的并发症。在这项研究中,我们旨在研究血管内治疗(EVT)对 AchoA 动脉瘤的安全性和疗效。
主要研究结果为血管造影和临床结果。次要研究结果变量包括短暂和永久性缺血性并发症、症状性脉络膜动脉闭塞和再治疗率。使用随机效应模型计算患病率及其相应的 95%置信区间(CI),并进行亚组分析以评估动脉型(直接起源于 ICA)和颈型(起源于 AchoA 分支)AchoA 动脉瘤、破裂与非破裂以及血流导向装置(FD)治疗与线圈治疗的并发症发生率。
我们的研究包括 10 项研究,共纳入 416 例 430 个 AchoA 动脉瘤患者。总体良好临床结局率(mRS 评分 0-2)为 94.5%,再治疗率为 2.0%。亚组分析显示,在完全闭塞方面,线圈治疗(75.3%)与血流导向装置治疗(80.9%)之间无统计学差异(p 值:0.62)。总体永久性并发症发生率为 1.4%(p 值:0.54),短暂性缺血性并发症发生率为 4.2%(p 值:0.61)。症状性脉络膜动脉闭塞发生率为 0.8%(p 值:0.51)。颈型 AchoA 动脉瘤的并发症发生率明显更高,为 9.8%(p 值<0.05),明显高于动脉型动脉瘤。与破裂性动脉瘤相比,未破裂性动脉瘤的临床结局明显更好(OR:0.11;[0.02;0.5],p 值:<0.05)。
血管内治疗 AchoA 动脉瘤的临床效果良好,再治疗和并发症发生率较低。线圈和血流导向装置在实现动脉瘤闭塞方面的结果相似。与未破裂性动脉瘤相比,破裂性动脉瘤的良好临床结局较低。颈型 AchoA 动脉瘤的并发症发生率明显高于动脉型。